MedPath

Gastroscopic Esophageal Prick Test in adult Eosinophilic Esophagitis Patients: a pilot study

Completed
Conditions
Eosinophilic Esophagitis, allergy, sensitizations, clinical trial, pilot study, dietary treatmentEosinophiele oesofagitis, allergie, sensibilisatie, klinische studie, pilot studie, dieetbehandeling
Registration Number
NL-OMON26684
Lead Sponsor
Investigator inintiated study, Academic Medical Center Amsterdam
Brief Summary

Digestive disease week 2017 oral presentation

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Previous diagnosis of active EoE confirmed by histopathology e.g. presence of >15 eosinophilic granulocytes per high power field (hpf) in mid or proximal esophageal biopsies

-Macroscopic disease remission or with very mild macroscopic abnormalities after four weeks of treatment with an elemental or elimination diet

Exclusion Criteria

-Inability to stop topical corticosteroids

-Inability to stop beta-blockers and ACE inhibitors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome parameters of our study are: (1) visible mucosal changes within 20 minutes after esophageal allergen injections, the acute response, and (2) visible mucosal changes after 24 hours, the delayed response.
Secondary Outcome Measures
NameTimeMethod
Secondly, we will compare the local sensitization patterns identified through EPT with those identified through SPT and serum allergen specific IgE testing. Finally, we will evaluate whether the allergens that tested positive on EPT were in agreement with the reported implicating foods in patients’ history.
© Copyright 2025. All Rights Reserved by MedPath